Clinical Trial Update: Schizophrenia Study In Adults [Phase 2]

View source ↗

Summary

A Phase 2 schizophrenia trial sponsored by GlaxoSmithKline has completed. The update notes the study status but does not provide results in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED